Peer-reviewedCC BYSexual medicine
Atorvastatin improves hyperlipidemia-induced erectile dysfunction via PKA-associated eNOS phosphorylation at the Ser633 site
Related
- Exercise training improves hepatic enzymes, body mass index, and cardiorespiratory fitness in adults with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
- Inhibition of 3-Phosphoinositide-Dependent Kinase 1 Improves Age-Associated Epidermal Dysfunction.
- Small-Nerve Fibre Pathology in Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Liver Fat/Inflammation and Improves with Weight Loss
- Withania somnifera (Ashwagandha) Improves Fitness in Aged Drosophila by Reducing AKT Phosphorylation
- Atorvastatin-associated liver injury: a structured narrative review of reporting signals, clinical phenotypes, and hepatic safety, 2023–2026
BibTeX
@article{anon2026atorvastatin,
title = {{Atorvastatin improves hyperlipidemia-induced erectile dysfunction via PKA-associated eNOS phosphorylation at the Ser633 site}},
journal = {Sexual medicine},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13677068},
note = {CC BY},
}
RIS
TY - JOUR
TI - Atorvastatin improves hyperlipidemia-induced erectile dysfunction via PKA-associated eNOS phosphorylation at the Ser633 site
PY - 2026
DA - 2026/10/18
JO - Sexual medicine
UR - https://europepmc.org/article/PMC/PMC13677068
SN - 2050-1161
ER -